With the specter of COVID-19 and daily twists and turns, last fall’s unusual presidential election served as an exciting live case study for a new Washington University course.
In 2020, so much about what we know to be normal came to a grinding halt for the WashU community. One week in March, we’re looking ahead to spring break, and then suddenly it’s an unending hiatus. Yet the work of the university, and its families, goes on.
WashU alumni are among the researchers working around-the-clock on the Pfizer-BioNTech vaccine. They say they won’t rest until there are no more deaths from COVID-19.
Chancellor Andrew D. Martin delivers his State of the University address and updates the campus community on the university’s resilience and perseverance.
Applications are now being accepted for the Specialized Programs of Research Excellence (SPORE) in Leukemia Career Enhancement Program and the Developmental Research Program, under principal investigator Daniel Link, MD, at the School of Medicine. Those interested should apply by April 30.
